Little to learn from phase II trials in small-cell lung cancer

Ann Oncol. 1999 Sep;10(9):1007-9. doi: 10.1023/a:1008306930860.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Carcinoma, Small Cell / drug therapy*
  • Carcinoma, Small Cell / mortality
  • Carcinoma, Small Cell / radiotherapy
  • Clinical Trials, Phase II as Topic
  • Combined Modality Therapy
  • Hematopoietic Cell Growth Factors / therapeutic use
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / mortality
  • Lung Neoplasms / radiotherapy
  • Randomized Controlled Trials as Topic
  • Recurrence
  • Survival Rate

Substances

  • Hematopoietic Cell Growth Factors